… Nebivolol is a third-generation beta (β)-blockers which has … , safety and tolerability of nebivolol
in hypertensive patients … cacy, tolerability and safety of nebivolol in hypertensive patients …

… We assessed the efficacy and safety of a fixed-dose combination of a vasodilating β blocker
(nebivolol) and an angiotensin II receptor blocker (valsartan) in adults with hypertension. …

… diabetes. This study strongly suggests that, with respect to reducing BP in hypertensive diabetic
patients, a daily dosage of nebivolol … setting aimed at evaluating safety only from an open…

… to evaluate the effects of nebivolol in patients with diabetes. As elder patients with diabetes
may suffer from … The results of a safety analysis confirmed a good safety profile for nebivolol. …

… The nitric oxide-mediated vasodilation observed with nebivolol … In this paper, the safety
profile and tolerability of nebivolol will … study on 30 hypertensive subjects with type II diabetes, …

… NO has powerful antiatherogenic effects and a decrease in NO production is associated
with a number of cardiovascular risk factors including hypertension, diabetes mellitus and …

… Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and
hypertension: a randomized controlled trial. JAMA. 2004;292(18):2227–2236. …

… diabetes] or ≤130/80 mm Hg [with diabetes]) after at least 4 weeks of treatment at the 10/320
mg/d dosage. If BP goal was not met after a minimum of 10 weeks on the 20/320 mg/d …

… whether efficacy-safety of nebivolol can be generalized … nebivolol as monotherapy versus
add-on therapy, (2) to assess the effect of nebivolol on ISH, (3) to assess the effect of nebivolol …

… Essential hypertension is associated with endothelial dysfunction [1] which is caused mainly
… in managing hypertensive patients with endothelial dysfunction eg those with diabetes …